Top U.S. Healthcare Institution Deploys DarioHealth's Full Suite, Contributing to 2025 Revenue Growth and Market Expansion
DarioHealth (NASDAQ: DRIO) has secured a partnership with a major U.S. healthcare research and medical institution, marking its second significant healthcare employer agreement. The partnership, which is already generating recurring revenue in 2025, involves the implementation of Dario's complete suite of AI-powered digital health solutions.
The institution will deploy Dario Health, Dario Mind, and Dario Move platforms, covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company's solutions have demonstrated above-average engagement rates and significant improvements in health metrics, including reductions in A1c, blood pressure, and MSK-related pain.
DarioHealth (NASDAQ: DRIO) ha siglato una partnership con una importante istituzione di ricerca e assistenza sanitaria negli Stati Uniti, segnando il suo secondo accordo significativo con un datore di lavoro nel settore sanitario. La partnership, che sta già generando entrate ricorrenti nel 2025, prevede l'implementazione della suite completa di soluzioni per la salute digitale potenziate dall'IA di Dario.
L'istituzione implementerà le piattaforme Dario Health, Dario Mind e Dario Move, coprendo diverse condizioni croniche tra cui diabete, ipertensione, gestione del peso, dolori muscoloscheletrici e salute comportamentale. Le soluzioni dell'azienda hanno dimostrato tassi di coinvolgimento superiori alla media e significativi miglioramenti nei parametri di salute, inclusi riduzioni dell'A1c, della pressione sanguigna e del dolore muscoloscheletrico.
DarioHealth (NASDAQ: DRIO) ha conseguido una asociación con una importante institución de investigación y atención médica en EE. UU., marcando su segundo acuerdo significativo con un empleador del sector salud. La asociación, que ya está generando ingresos recurrentes en 2025, implica la implementación de la suite completa de soluciones de salud digital impulsadas por IA de Dario.
La institución desplegará las plataformas Dario Health, Dario Mind y Dario Move, abarcando múltiples condiciones crónicas, incluyendo diabetes, hipertensión, manejo de peso, dolor musculoesquelético y salud conductual. Las soluciones de la empresa han demostrado tasas de participación superiores a la media y mejoras significativas en los indicadores de salud, incluyendo reducciones en A1c, presión arterial y dolor relacionado con el sistema musculoesquelético.
DarioHealth (NASDAQ: DRIO)는 미국의 주요 의료 연구 및 의료 기관과 파트너십을 체결하여 두 번째 주요 의료 고용주 계약을 체결했습니다. 이 파트너십은 이미 2025년에 반복 수익을 창출하고 있으며, Dario의 AI 기반 디지털 건강 솔루션 전체 제품군을 구현하는 것을 포함합니다.
이 기관은 Dario Health, Dario Mind, Dario Move 플랫폼을 배포하여 당뇨병, 고혈압, 체중 관리, 근골격계 통증 및 행동 건강을 포함한 여러 만성 질환을 다룰 것입니다. 이 회사의 솔루션은 평균 이상의 참여율과 A1c, 혈압 및 근골격계 관련 통증 감소를 포함한 건강 지표에서 상당한 개선을 보여주었습니다.
DarioHealth (NASDAQ: DRIO) a conclu un partenariat avec une grande institution de recherche et de santé américaine, marquant son deuxième accord significatif avec un employeur du secteur de la santé. Ce partenariat, qui génère déjà des revenus récurrents en 2025, implique la mise en œuvre de l'ensemble des solutions de santé numérique alimentées par l'IA de Dario.
L'institution déploiera les plateformes Dario Health, Dario Mind et Dario Move, couvrant plusieurs maladies chroniques, y compris le diabète, l'hypertension, la gestion du poids, la douleur musculosquelettique et la santé comportementale. Les solutions de l'entreprise ont montré des taux d'engagement supérieurs à la moyenne et des améliorations significatives des indicateurs de santé, notamment des réductions de l'A1c, de la pression artérielle et de la douleur liée au système musculosquelettique.
DarioHealth (NASDAQ: DRIO) hat eine Partnerschaft mit einer bedeutenden US-amerikanischen Forschungs- und Gesundheitseinrichtung gesichert, was die zweite bedeutende Vereinbarung mit einem Arbeitgeber im Gesundheitswesen darstellt. Die Partnerschaft, die bereits im Jahr 2025 wiederkehrende Einnahmen generiert, umfasst die Implementierung des vollständigen Portfolios von KI-gestützten digitalen Gesundheitslösungen von Dario.
Die Einrichtung wird die Plattformen Dario Health, Dario Mind und Dario Move einsetzen, die mehrere chronische Erkrankungen abdecken, darunter Diabetes, Bluthochdruck, Gewichtsmanagement, muskuloskelettale Schmerzen und psychische Gesundheit. Die Lösungen des Unternehmens haben überdurchschnittliche Engagement-Raten und signifikante Verbesserungen der Gesundheitskennzahlen gezeigt, einschließlich Reduzierungen bei A1c, Blutdruck und MSK-bezogenen Schmerzen.
- Already generating recurring revenue in 2025
- Second major healthcare employer partnership secured
- Full suite deployment demonstrates strong product adoption
- Above-industry-average engagement rates
- Proven clinical outcomes in multiple health metrics
- None.
Insights
DarioHealth's partnership with a major U.S. healthcare institution represents a significant positive development for the company's growth trajectory. The deal is already
This second major healthcare employer win demonstrates accelerating market traction in the enterprise segment, which typically yields higher-value, longer-term contracts than consumer-direct business. The full suite deployment (spanning diabetes, hypertension, weight management, MSK, and behavioral health) maximizes revenue potential per client and validates Dario's comprehensive platform approach in a market where point solutions often struggle.
The description of the client as a "nationally strategic institution with a central role in U.S. healthcare" suggests this could serve as a reference customer with substantial influence in the healthcare sector. For a company with a market cap of just
The highlighted engagement metrics and clinical outcomes (reductions in A1c, blood pressure, MSK pain) indicate the platform is delivering measurable results, which is crucial for retention and expansion within enterprise accounts. For Dario, whose stock currently trades at less than $0.58 per share, this enterprise validation could help shift market perception from a struggling digital health player to a viable contender in the competitive employer benefits space.
This partnership represents a significant technological validation for DarioHealth's AI-driven chronic condition management platform. The healthcare institution's decision to implement the full suite of Dario solutions signals confidence in the company's integrated approach to managing multiple chronic conditions through a single platform.
The emphasis on "data-driven support" and "personalization" aligns with the evolving healthcare technology landscape, where generic wellness applications are increasingly being replaced by solutions demonstrating measurable outcomes. Particularly noteworthy is the client's identity as a research institution, suggesting rigorous evaluation criteria were applied in the vendor selection process.
From a competitive standpoint, Dario's ability to secure another major healthcare employer strengthens its position against larger digital health platforms and point solutions. The healthcare employer segment is highly strategic as these institutions serve as both users and potential validators of digital health technologies.
The implementation spans multiple high-cost chronic conditions (diabetes, hypertension, weight management, MSK, behavioral health), addressing conditions that collectively represent a substantial portion of employer healthcare costs. By demonstrating "significant reductions in A1c, blood pressure, and MSK-related pain," Dario is targeting metrics directly tied to healthcare utilization and costs, which strengthens its ROI narrative to prospective clients.
For a company of Dario's size, securing contracts with prestigious healthcare institutions provides credibility that can accelerate sales cycles with other enterprise prospects, potentially creating a network effect within the healthcare community.
Second major healthcare employer signs with DarioHealth, accelerating growth in 2025 and reinforcing its leadership in AI-powered, clinically validated digital health solutions for chronic condition management
Chosen for its proven impact, personalization, and seamless integration, Dario's AI-driven platform will provide employees with data-driven support through its full suite of solutions—Dario Health, Dario Mind, and Dario Move—spanning multiple chronic conditions, including diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
"In today's competitive benefits landscape, employers are demanding solutions that deliver real-world results — not just promises," said Steven Nelson, Chief Commercial Officer of DarioHealth. "We believe this partnership sends a strong signal that leading organizations are moving beyond generic wellness apps and toward data-driven platforms that scale quickly and demonstrate clinical, financial, and cultural ROI. Dario is proving that we're not only easy to deploy, but powerful enough to meet the performance standards of the most demanding enterprise workforces in the country."
The newly added employer is a nationally strategic institution with a central role in
Dario's momentum in the employer space continues to build, with engagement rates well above industry averages and early outcomes showing significant reductions in A1c, blood pressure, and MSK-related pain—alongside measurable improvements in mental well-being. The agreement provides further market validation of Dario's approach as a scalable, clinically integrated solution. As digital health adoption accelerates, Dario believes that partnerships with leading healthcare systems will be a key marker of trust and reliability in the sector.
About DarioHealth Corp.
DarioHealth Corp. (NASDAQ: DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Dario's platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care, and consumers. To learn more about Dario and its digital health solutions, or for more information, visit http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the expectation that the agreement will generate recurring revenue in 2025, its belief that Dario's AI-driven platform will provide employees with data-driven support through its full suite of solutions, the forecast that leading organizations are moving beyond generic wellness apps and toward data-driven platforms, its belief that the Dario platform is powerful enough to meet the performance standards of the most demanding enterprise workforces in the country, that Dario's momentum in the employer space continues to build, and its belief that partnerships with leading healthcare systems will be a key marker of trust and reliability in the sector. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the
DarioHealth Corporate Contact:
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280
DarioHealth Investor Relations Contact:
Kat Parrella
Investor Relations Manager
kat@dariohealth.com
+315-378-6922
Logo: https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/top-us-healthcare-institution-deploys-dariohealths-full-suite-contributing-to-2025-revenue-growth-and-market-expansion-302423158.html
SOURCE DarioHealth Corp.
FAQ
What healthcare solutions are included in DarioHealth's (DRIO) full suite deployment?
What clinical outcomes has DRIO demonstrated in their digital health platform?
When will the new healthcare institution partnership start generating revenue for DRIO?
How many major healthcare employers has DRIO secured partnerships with?
